BioVie Inc
NASDAQ:BIVI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
BioVie Inc (BIVI) under the Base Case is USD per share.
Compared with the current market price of 1.33 USD, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What BioVie Does
BioVie is a clinical-stage biotechnology company that develops drug candidates for serious diseases, with a focus on neurodegenerative and liver disorders. Its main programs are based on trying to reduce inflammation and other disease processes that may help conditions such as Alzheimer’s disease, Parkinson’s disease, and liver disease. At this stage, it does not sell a commercial drug portfolio like a large pharmaceutical company; instead, it is building and testing its pipeline through clinical research.
- Headquarters
- United States of America US
- Employees
- 13
- IPO date
- Jan 14, 2014
Revenue & Expenses Breakdown
BioVie Inc
Earnings Waterfall
BioVie Inc
What is the Intrinsic Value of one BIVI stock?
The intrinsic value for BioVie Inc (BIVI) under the Base Case is USD.
Is BIVI stock undervalued or overvalued?
Compared with the current market price of 1.33 USD, the stock appears .
